Big Popes: bargain hunting among the stock market's beaten-down giants

Big Popes: how to spot bargains among the stock market's giants

In recent months, volatility has created a peculiar category of opportunity: leading companies with solid business models trading at rock-bottom prices due to temporary risk narratives. Long-memory investors call these situations "Big Popes": companies that haven't lost their competitive edge, but have been abandoned by the market over antiestéticars that tend to fade with time.

What makes a stock a "Big Pope"?

Not just any drop qualifies. The key is that the plunge stems from an extreme valuation caused by external or regulatory risks, not from a structural deterioration of the business. Bayer is the textbook example: its share price collapsed over the glyphosate litigation, but it remains a pharmaceutical giant with a patent portfolio and cash flow that don't justify the lows it hit. Other recurring cases in the analysis are Adobe, which has fallen on uncertainty about its subscription model yet retains a formidable competitive moat, and Alibaba, punished by the risk of delisting in the US — a political risk, not an operational one.

Controversial cases: when the drop signals something worse

Not every cheap stock is a Big Pope. Nike has fallen 63% from its highs, but detailed analysis suggests the brand is losing steam: it's not a narrative, it's a downward rerating. Something similar is happening with Diageo: its spirits business faces a trend of lower consumption among young people, although its ability to generate margins and its competitive advantage (a 15-year whisky requires 15 years of maturation) keep the debate open. The dividing line is thin: a company can be "cheap junk" and still deliver returns if the market overreacts.

The most concrete opportunities on the table

Among the candidates with the greatest medium-term potential, Atresmedia stands out: after adding more than 100 million euros in recurring revenue and divesting from Fever Labs (with a 7x return), it could reach a P/E of 15 and revenue of 1.4 billion. Grifols, after Brookfield's failed takeover bid, is back at levels suggesting potential to double if EBITDA keeps improving. And Accenture, in oversold territory that by some calculations puts it at a market extreme, could easily double. The trick is to wait for the bottom, not to catch the falling knife.

The detailed valuation calculations for each case, including earnings scenarios and target multiples, are the material that really makes the difference. It's not about buying and praying, but about building a portfolio with dry powder to keep adding positions as the negative narrative reaches its climax.

With markets at all-time highs and geopolitical tension over Iran adding volatility, now may be the perfect time to have a list of Big Popes ready. But as the analysis reminds us, market timing is hard: better to be patient and wait for the price to confirm that the bottom is in.